Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Soins; La Revue De Reference Infirmiere|January 14, 2014
[History and care of malignant wounds in breast cancer]Isabelle Fromantin, Séverine Alran, Nathalie Cassoux
Journal of Perinatal Medicine|April 11, 2006
Vaginal birth after cesarean section: X-ray pelvimetry at term is informativeOlivier Sibony, Séverine Alran, Jean-François Oury
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 1, 2002
Differences in management and results in term-delivery in nine European referral hospitals: descriptive studySéverine Alran, Olivier Sibony, Jean-François Oury, et al.
American Journal of Obstetrics and Gynecology|December 14, 2004
Paris heat wave and oligohydramniosDominique Luton, Séverine Alran, Virginie Fourchotte, et al.
Acta Obstetricia Et Gynecologica Scandinavica|May 18, 2004
Maternal and neonatal outcome of 93 consecutive triplet pregnancies with 71% vaginal deliverySéverine Alran, Olivier Sibony, Dominique Luton, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 8, 2010
Pathologic response rate after concomitant neo-adjuvant radiotherapy and chemotherapy for adenocarcinoma of the uterine cervix: a retrospective multicentric studyOlivier Poujade, Philippe Morice, Roman Rouzier, et al.
British Journal of Cancer|April 26, 2017
Preoperative clinical pathway of breast cancer patients: determinants of compliance with EUSOMA quality indicatorsDelphine Héquet, Cyrille Huchon, Sandrine Baffert, et al.
Breast (Edinburgh, Scotland)|April 26, 2012
High Ki67 expression is a risk marker of invasive relapse for classical lobular carcinoma in situ patientsAnne Vincent-Salomon, David Hajage, Alexandre Rouquette, et al.
American Journal of Clinical Oncology|March 2, 2011
Pathologic response to short intensified taxane-free neoadjuvant chemotherapy in patients with highly proliferative operable breast cancerChristophe Le Tourneau, Sarah Dettwiler, Philippe Beuzeboc, et al.
International Journal of Breast Cancer|June 14, 2013
Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 StudyFrançois-Clément Bidard, Lisa Belin, Suzette Delaloge, et al.
Pageof 3